Evidence map›Paper›PMID 33353148›Full record

ArticleCancers2020

Germline Genetic Variants of the Renin-Angiotensin System, Hypoxia and Angiogenesis in Non-Small Cell Lung Cancer Progression: Discovery and Validation Studies.

Maria Joana Catarata, Rui Medeiros, Maria José Oliveira, Alice Pêgo, João Gonçalo Frade, Maria Fátima Martins, Carlos Robalo Cordeiro, Felix J F Herth, Michael Thomas, Mark Kriegsmann and 4 more

Abstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Maria Joana Cataratai3S-Institute for Research & Innovation in Health, University of Porto, 4200-135 Porto, Portugal.
Rui MedeirosFaculty of Medicine, University of Porto, 4200-319 Porto, Portugal.ORCID 0000-0003-3010-8373
Maria José Oliveirai3S-Institute for Research & Innovation in Health, University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-0724-0272
Alice PêgoDepartment of Pulmonology, Coimbra Hospital and University Center, 3000-075 Coimbra, Portugal.
João Gonçalo FradeDepartment of Clinical Pathology, Coimbra Hospital and University Center, 3000-075 Coimbra, Portugal.
Maria Fátima MartinsDepartment of Clinical Pathology, Coimbra Hospital and University Center, 3000-075 Coimbra, Portugal.
Carlos Robalo CordeiroDepartment of Pulmonology, Coimbra Hospital and University Center, 3000-075 Coimbra, Portugal.
Felix J F HerthDepartment of Pulmonology and Critical Care Medicine, Thoraxklinik, University of Heidelberg, 69126 Heidelberg, Germany.
Michael ThomasTranslational Lung Research Centre (TLRC), member of the German Centre for Lung Research (DZL), 69120 Heidelberg, Germany.
Mark KriegsmannTranslational Lung Research Centre (TLRC), member of the German Centre for Lung Research (DZL), 69120 Heidelberg, Germany.ORCID 0000-0002-7319-3646
Michael MeisterTranslational Lung Research Centre (TLRC), member of the German Centre for Lung Research (DZL), 69120 Heidelberg, Germany.
Marc A SchneiderTranslational Lung Research Centre (TLRC), member of the German Centre for Lung Research (DZL), 69120 Heidelberg, Germany.ORCID 0000-0001-8269-3821
Thomas MuleyTranslational Lung Research Centre (TLRC), member of the German Centre for Lung Research (DZL), 69120 Heidelberg, Germany.
Ricardo Ribeiroi3S-Institute for Research & Innovation in Health, University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0001-9785-857X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe renin-angiotensin system (RAS) is involved in cell proliferation, immunoinflammatory response, hypoxia and angiogenesis, which are critical biological processes in lung cancer. Our aim was to study the association of putatively functional genetic polymorphisms in genes coding for proteins involved in RAS, hypoxia and angiogenesis with non-small cell lung cancer (NSCLC) prognosis.

methodsGenotyping of 52 germline variants from genes of the RAS and hypoxic/angiogenic factors/receptors was performed using MassARRAY iPLEX Gold in a retrospective cohort (

resultsMultivariate analysis on the discovery set revealed that

conclusionThis study provides evidence that

Indexed as

angiogenesisgenetic polymorphismshypoxialung cancerrenin–angiotensin

Identifiers

PMID33353148
PMCPMC7766842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.